Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Preferred Dividend Payments (2016 - 2017)

Viridian Therapeutics, Inc.\DE has reported Preferred Dividend Payments over the past 2 years, most recently at $5000.0 for Q1 2017.

  • For Q1 2017, Preferred Dividend Payments rose 141.67% year-over-year to $5000.0; the TTM value through Dec 2017 reached $5000.0, down 80.0%, while the annual FY2017 figure was $5000.0, 89.8% down from the prior year.
  • Preferred Dividend Payments for Q1 2017 was $5000.0 at Viridian Therapeutics, Inc.\DE, down from $12000.0 in the prior quarter.
  • Over five years, Preferred Dividend Payments peaked at $13000.0 in Q3 2016 and troughed at -$12000.0 in Q1 2016.